Efbemalenograstim alfa as prophylaxis for chemotherapy-induced neutropenia in patients with non–small-cell lung cancer: a randomized, multicenter, phase II trial
- DOI
- 10.20892/j.issn.2095-3941.2026.0311
- Published
- 2026-09-17
- Container
- Cancer Biology & Medicine
- Publisher
- China Anti-cancer Association
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.20892/j.issn.2095-3941.2026.0311,
title = {Efbemalenograstim alfa as prophylaxis for chemotherapy-induced neutropenia in patients with non\&\#x2013;small-cell lung cancer: a randomized, multicenter, phase II trial},
author = {Mengjie Li and Caixia Liu and Fengming Ran and Haitao Lan and Jun Ge and Zheng Zhao and Chuangzhou Rao and Wei Zheng and Xiaoyong Tang and Tianhui Gao and Yong Mao and Wei Cui and Zhengguo Li and Dingzhi Huang},
year = {2026},
journal = {Cancer Biology \& Medicine},
doi = {10.20892/j.issn.2095-3941.2026.0311},
url = {https://doi.org/10.20892/j.issn.2095-3941.2026.0311}
}RIS
TY - JOUR TI - Efbemalenograstim alfa as prophylaxis for chemotherapy-induced neutropenia in patients with non–small-cell lung cancer: a randomized, multicenter, phase II trial AU - Mengjie Li AU - Caixia Liu AU - Fengming Ran AU - Haitao Lan AU - Jun Ge AU - Zheng Zhao AU - Chuangzhou Rao AU - Wei Zheng AU - Xiaoyong Tang AU - Tianhui Gao AU - Yong Mao AU - Wei Cui AU - Zhengguo Li AU - Dingzhi Huang PY - 2026 JO - Cancer Biology & Medicine DO - 10.20892/j.issn.2095-3941.2026.0311 UR - https://doi.org/10.20892/j.issn.2095-3941.2026.0311 ER -
APA
Li, M., Liu, C., Ran, F., Lan, H., Ge, J., Zhao, Z., Rao, C., Zheng, W., Tang, X., Gao, T., Mao, Y., Cui, W., Li, Z., & Huang, D. (2026). Efbemalenograstim alfa as prophylaxis for chemotherapy-induced neutropenia in patients with non–small-cell lung cancer: a randomized, multicenter, phase II trial. Cancer Biology & Medicine. https://doi.org/10.20892/j.issn.2095-3941.2026.0311
Source records
- crossref · retrieved 2026-09-26T07:46:41.639Z